AI Used in New COVID-19 Test Improves Accuracy
The test, approved for medical use in the United Kingdom, was found to be highly accurate with a detection rate of 98% and a specificity of 100%.
The test, approved for medical use in the United Kingdom, was found to be highly accurate with a detection rate of 98% and a specificity of 100%.
Cough characteristics in COVID-19 patients could offer a quick and cost-effective method for identifying the severity of the disease in patients.
A closer look as some of the latest spirometers and pulmonary function testing (PFT) diagnostic devices on the market from coVita, FutureMed, MGC Diagnostics, and Vitalograph.
The clearance allows FebriDx to be marketed in the United States for use by healthcare professionals as an aid in the diagnosis of bacterial acute respiratory infection and differentiation from non-bacterial etiology in patients presenting in urgent care or emergency care settings.
Read MoreResearchers at Washington University in St. Louis found that even while pulse oximeters have been adjusted to account for darker skin tones, the bias remains and must be fixed.
Read MoreResearchers found that a race-specific approach to lung function testing resulted in a lower lung allocation score for Black patients and higher lung allocation score for White patients, which may have contributed to racially biased allocation of lung transplants.
Read MoreA newly developed PET imaging agent can non-invasively identify pulmonary fibrosis in its early stages, reducing the need for unnecessary biopsies and allowing patients to begin treatment sooner.
Read MoreCaire’s Fenom Pro fractional exhaled nitric oxide (FeNO) device can now be upgraded to include a 6-second test mode available for ages 6 and up.
Read MoreA new study suggests CT results alone may not confer as much risk as traditionally thought—a finding that will come as a surprise to most emergency physicians, according to one of the study’s authors.
Read MoreNew research demonstrates the ability of a new respiratory responsive vocal biomarker machine-learning model to differentiate patients with COVID-19 from healthy individuals with about 70% accuracy.
Read MoreThe tool, which has been granted FDA Breakthrough Device Designation, is being developed to serve as adjunct in assessment of ILD, potentially avoiding expensive, invasive surgical testing.
Read MoreAccording to Hologic, the test will be a critical tool this upcoming season to help clinicians determine which respiratory virus or coinfection patients have to better inform the best course of treatment.
Read MoreThe test can help physicians diagnose long COVID, differentiate it from diseases with similar symptoms, and provide insights into personalized treatment approaches.
Read MoreWhen compared to PCR, the gold standard COVID test, breathalyzer results matched 85% of the time. For medical diagnostics, accuracy of 80% or greater is considered “excellent.”
Read MoreThe device’s manufacturer believes the availability of RRp and thermometry may play a role in assisting clinicians and as they seek to combat numerous types of illnesses, including pneumonia and other respiratory viruses.
Read More